Jiahao Hu Selected Research

Jiahao Hu Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 01/2014
9	Gallbladder Neoplasms (Gallbladder Cancer) 02/2024 - 01/2020
6	Inflammation (Inflammations) 03/2024 - 10/2020
5	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 10/2020
2	Mucopolysaccharidoses 08/2021 - 08/2019
1	Autoimmune Diseases (Autoimmune Disease) 04/2024
1	Abscess 03/2024
1	Osteomyelitis 03/2024
1	Bursitis (Adhesive Capsulitis) 02/2024
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2024
1	Respiratory Hypersensitivity 12/2023
1	Asthma (Bronchial Asthma) 12/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023
1	Wounds and Injuries (Trauma) 10/2023
1	Herpes Zoster 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Insulin Resistance 01/2022
1	Fatty Liver 01/2022
1	Gaucher Disease (Gaucher's Disease) 08/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 08/2021
1	Glycogen Storage Disease Type II (Pompe's Disease) 08/2021
1	Hypoxia (Hypoxemia) 10/2020
1	Fibrosis (Cirrhosis) 10/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2022
3	HydrogelsIBA 03/2024 - 10/2023
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2024
2	Liposomes (Liposome)IBA 11/2023 - 10/2023
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2023 - 10/2023
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2023
1	LipidsIBA 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2024
1	PolylysineIBA 03/2024
1	AcidsIBA 03/2024
1	Polyvinyl AlcoholIBA 03/2024
1	Metal-Organic FrameworksIBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 02/2024
1	adavosertibIBA 02/2024
1	Hyaluronic Acid (Hyaluronan)IBA 02/2024
1	Poloxamer (Poloxamer 407)IBA 02/2024
1	AZD4547IBA 01/2024
1	Interleukin-5 (Interleukin 5)IBA 12/2023
1	Interleukin-4 (Interleukin 4)IBA 12/2023
1	OvalbuminIBA 12/2023
1	Interleukin-27 (Interleukin 27)IBA 12/2023
1	Interleukin-17 (Interleukin 17)IBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	Immunoglobulin E (IgE)IBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	Interleukin-13IBA 12/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2023
1	O-GlcNAc transferaseIBA 11/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 10/2023
1	Caspase 3 (Caspase-3)IBA 10/2023
1	CollagenIBA 10/2023
1	SolutionsIBA 10/2023
1	Toll-Like Receptor 4IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Mucin-2IBA 01/2023
1	InterferonsIBA 01/2023
1	MucinsIBA 01/2023
1	Trefoil Factor-3IBA 01/2023
1	Tight Junction ProteinsIBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	OccludinIBA 01/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	IronIBA 12/2022
1	CarbohydratesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Soybean Oil FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	fas Receptor (CD95 Antigen)IBA 01/2022
1	Fatty Acid-Binding ProteinsIBA 01/2022
1	lardIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Penfluridol (Semap)IBA 01/2022
1	Circular RNAIBA 11/2021
1	imiglucerase FDA Link 08/2021
1	EnzymesIBA 08/2021
1	Sorafenib (BAY 43-9006)FDA Link 02/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	regorafenibIBA 10/2020
1	human GALNS proteinIBA 08/2019

Therapy/Procedure

11	Therapeutics 02/2024 - 01/2014
3	Immunotherapy 04/2024 - 01/2023
2	Hepatectomy 01/2023 - 01/2021
1	Injections 02/2024
1	Stem Cell Transplantation 01/2024
1	Time-to-Treatment 01/2023
1	Cholecystectomy 01/2023
1	Photochemotherapy (Photodynamic Therapy) 01/2023
1	Phototherapy (Light Therapy) 01/2023
1	Intravenous Administration 01/2023